Self-sampling tools to increase cancer screening among underserved patients: a pilot randomized controlled trial
JNCI Cancer Spectrum · 04.01.2024 · 8 (1)
DOI: 10.1093/jncics/pkad103 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 07.12.2023. Verfasst von Jennifer L Moss und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family and Community Medicine, Penn State College of Medicine, The Pennsylvania State University, Hershey, PA, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Papillomavirus Infections, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Screening can reduce cancer mortality, but uptake is suboptimal and characterized by disparities. Home-based self-sampling can facilitate screening for colorectal cancer (with stool tests, eg, fecal immunochemical tests) and for cervical cancer (with self-collected human papillomavirus tests), especially among patients who face barriers to accessing health care. Additional data are needed on feasibility and potential effects of self-sampling tools for cancer screening among underserved patients.
Methods
We conducted a pilot randomized controlled trial with patients (female, ages 50-65 years, out of date with colorectal and cervical cancer screening) recruited from federally qualified health centers in rural and racially segregated counties in Pennsylvania. Participants in the standard-of-care arm (n = 24) received screening reminder letters. Participants in the self-sampling arm (n = 24) received self-sampling tools for fecal immunochemical tests and human papillomavirus testing. We assessed uptake of screening (10-week follow-up), self-sampling screening outcomes, and psychosocial variables. Analyses used Fisher exact tests to assess the effect of study arm on outcomes.
Results
Cancer screening was higher in the self-sampling arm than the standard-of-care arm (colorectal: 75% vs 13%, respectively, odds ratio = 31.32, 95% confidence interval = 5.20 to 289.33; cervical: 79% vs 8%, odds ratio = 72.03, 95% confidence interval = 9.15 to 1141.41). Among participants who returned the self-sampling tools, the prevalence of abnormal findings was 24% for colorectal and 18% for cervical cancer screening. Cancer screening knowledge was positively associated with uptake (P < .05).
Conclusions
Self-sampling tools can increase colorectal and cervical cancer screening among unscreened, underserved patients. Increasing the use of self-sampling tools can improve primary care and cancer detection among underserved patients. Clinical Trials Registration Number STUDY00015480.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Family and Community Medicine, Penn State College of Medicine, The Pennsylvania State University, Hershey, PA, USA.
- Department of Public Health Sciences, Penn State College of Medicine, The Pennsylvania State University, Hershey, PA, USA.
- Huntsman Cancer Institute, Salt Lake City, UT, USA.
- Department of Population Health Sciences, School of Medicine, University of Utah, Salt Lake City, UT, USA.
- Department of Health Behavior and Health Promotion, College of Public Health, The Ohio State University, Columbus, OH, USA.
- Department of Surgery, Washington University School of Medicine in St Louis, St Louis, MO, USA.
ORCID-Profile: Jennifer L Moss, Juliette Entenman, Kelsey Stoltzfus, Jiangang Liao, Tracy Onega, Paul L Reiter, Lisa M Klesges, George Garrow, Mack T Ruffin
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- NIH HHS
- National Cancer Institute
- National Institutes of Health
- National Center for Advancing Translational Sciences
Zitieren
APA
Moss, J. L., Entenman, J., Stoltzfus, K., Liao, J., Onega, T., Reiter, P. L., Klesges, L. M., Garrow, G., & Ruffin, M. T. (2024). Self-sampling tools to increase cancer screening among underserved patients: a pilot randomized controlled trial. JNCI Cancer Spectrum, 8(1). https://doi.org/10.1093/jncics/pkad103
Vancouver
Moss JL, Entenman J, Stoltzfus K, Liao J, Onega T, Reiter PL, et al. Self-sampling tools to increase cancer screening among underserved patients: a pilot randomized controlled trial. JNCI Cancer Spectrum. 2024;8(1). doi:10.1093/jncics/pkad103
BibTeX
@article{Moss2024,
author = {Moss, Jennifer L and Entenman, Juliette and Stoltzfus, Kelsey and Liao, Jiangang and Onega, Tracy and Reiter, Paul L and Klesges, Lisa M and Garrow, George and Ruffin, Mack T},
title = {Self-sampling tools to increase cancer screening among underserved patients: a pilot randomized controlled trial},
journal = {JNCI Cancer Spectrum},
year = {2024},
volume = {8},
number = {1},
doi = {10.1093/jncics/pkad103}
}
EUVIMED